Table 1

ANDI call for Center of Excellence results
Countries Applications Regions Functional competency R&D area
Basic Research Product Discovery Traditional Medicines Preclinical development Clinical development Manufacturing Product Evaluation1 Other2
Algeria 2 (3) North - - - - - - 1 2
Egypt 12 (13) 2 5 1 - - 1 2 2
Morocco 2 (4) - 2 - - - - - 2
Tunisia 2 - 1 - - - - 1 -
Ethiopia 2 East - - 1 - - - 1 -
Kenya 13 2 1 2 2 2 1 1 2
Sudan 1 - 1 - - - - - -
Tanzania 3 1 1 - - - 1 - -
Uganda 11 (12) 1 1 1 - 4 1 2 2
Botswana 1 South - - - - - 1 - -
Mauritius 1 - 1 - - - - - -
Mozambique 1 - - - - 1 - - -
South Africa 24 8 9 - 1 1 1 - 4
Zambia 1 - - - - - - 1 -
Zimbabwe 2 (4) 1 2 - - 1 - - -
Benin 1 West - - - - - - - 1
Burkina Faso 3 - 2 - - 1 - - -
Côte d'Ivoire 1 - - - - - - - 1
Ghana 5 (6) 1 2 1 - 1 1 - -
Mali 1 - - - - 1 - - -
Nigeria 16 (21) - 7 8 2 2 - - 2
Senegal 1 - - 1 - - - - -
Cameroon 6 (7) Central 1 3 2 - - - - 1
Chad 1 (2) - - - - - - 1 1
Democratic Republic of Congo 3 - 1 - - - - 1 1
Republic of Congo 1 - - - - - - - 1
Total 117 (132) 18 39 17 5 14 7 11 22

1 Activities related to evaluation of new or already registered products or available technology including implementation research, or diagnostics performance evaluation etc.

2 Epidemiology, Health Systems, Ethics, IP management, Knowledge & data management.

This table shows specific number of applications received by countries and regions as well as functional R&D competency areas that were covered by application received. Total number of applications per competency area received is 132, which is higher than the total number of individual applications which is 117. The reason for this is that some applications did apply to be considered for two or more competency areas within their single application. Numbers in the Applications column represent the number of individual application per country (in bold, 117 in total) and the number of competency areas covered by the applications (in brackets, 132 in total). Please note that the competency areas outlined (mirror the call), and these were all covered in the applications received and cover the different part of the product R&D value chain.

Nwaka et al.

Nwaka et al. BMC International Health and Human Rights 2012 12:11   doi:10.1186/1472-698X-12-11

Open Data